Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment [Phase 4]
This Phase 4 trial evaluated trastuzumab (Herceptin) in combination with a taxane in patients with HER2-positive breast cancer who relapsed …
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer [Phase 1]
This document reports a completed Phase 1 clinical trial evaluating celecoxib in postmenopausal women undergoing surgery for invasive breast…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer [Phase 1]
This is a Phase I prevention trial evaluating atorvastatin in women at increased risk for breast cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Efficacy of Thoracic Paravertebral Block in the Reduction of Acute Post-surgical Pain in Patients With Breast Cancer [Phase 3]
A Phase 3 trial evaluated whether thoracic paravertebral block reduces acute postoperative pain in breast cancer surgery. The study has comp…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Specimen X-Rays of Removed Axillary Lymph Nodes to Guide Pathological Sampling
A completed trial evaluated whether specimen X-rays of removed axillary lymph nodes can guide targeted pathological sampling in breast cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients [NA]
The study evaluating doxorubicin-associated cardiac remodeling with cardiac MRI in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life [NA]
A completed clinical trial comparing progressive resistance training versus relaxation in breast cancer patients undergoing chemotherapy, in…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Breast Cancer Risk Biomarkers in Postmenopausal Women [Phase 2]
Phase 2 trial investigating breast cancer risk biomarkers in postmenopausal women; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females [Phase 1]
This Phase 1 dose-finding trial evaluated subcutaneous trastuzumab (Herceptin) in healthy male volunteers and HER2-positive females with bre…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer [Phase 1]
Phase 1 trial evaluating a peptide-based vaccine designed to elicit T cell responses in patients with breast cancer; the study has completed…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on ABI-007 (Abraxane) in taxol-resistant metastatic breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer [Phase 1]
This Phase 1 trial evaluated GDC-0941 (pictilisib) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with let…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating pazopanib for recurrent or metastatic breast cancer has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). [Phase 1]
This Phase 1 study evaluated the combination of lurbinectedin with capecitabine in patients with metastatic breast cancer, pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Upper Limb Muscular Strengthening in the Rehabilitation of Patients Submitted to the Breast Cancer Surgical Treatment [NA]
A completed clinical trial assessing upper limb muscular strengthening for rehabilitation after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Citalopram in Treating Postmenopausal Women With Hot Flashes [Phase 3]
Phase 3 clinical trial evaluating citalopram for treating hot flashes in postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan in combination with docetaxel for refractory metastatic breast cancer; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase II clinical trial evaluating the combination of irinotecan and cetuximab in patients with metastatic breast cancer; the study status i…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy [Phase 2]
Extension Phase 2 study evaluating the combination of lapatinib with trastuzumab (Herceptin) with or without endocrine therapy in breast can…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer [Phase 3]
This ClinicalTrials.gov update reports on a Phase 3 diagnostic accuracy and safety study evaluating fluoroestradiol (FES) PET/CT for assessi…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer
A completed clinical trial evaluated circulating microRNA as a biomarker of cardiotoxicity in breast cancer. The study sponsor is West Pomer…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: The Effect of Reflexology on Radiation-related Fatigue in Breast Cancer Patients [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated whether reflexology reduces radiation-related fatigue in breast cancer patients; results were pos…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane [Phase 2]
A Phase 2 clinical trial update evaluating the combination of erlotinib and gemcitabine in patients with metastatic breast cancer who were p…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating LY231514 plus gemcitabine for metastatic breast cancer in wo…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating docetaxel, capecitabine, and bevacizumab for metastatic breast cancer has completed.